RSV ComNet I: measuring the clinical and socioeconomic burden of RSV in young children (< 5 years) in primary care, 2019-2020
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections in children. By the age of one, 60–70% of children have been infected by RSV (2%-3% of whom are hospitalized), and almost all children have been infected by two years of age. A global burden of disease study has recently shown that RSV is estimated to cause approximately 33.8 million new episodes of acute lower respiratory infections annually in children aged <5 years worldwide, resulting in 3.2 million hospital admissions and 59,600 in-hospital deaths in children aged <5 years in 2015. RSV is also recognized as a cause of illness in adults and high-risk adults, with a disease burden similar to that of seasonal influenza A.
To develop a protocol for measuring the clinical and socioeconomic burden of RSV in young children (<5 years) in primary care, and to do a first pilot measurement.
For the Dutch influenza surveillance, the general practitioners of the Pilot Stations (part of Nivel Zorgregistraties Eerste Lijn) are asked to send in weekly samples of patients with an influenza-like illness or another acute respiratory infection. These samples are examined at the RIVM for influenza virus, rhinovirus, RSV and enterovirus. The general practitioners receive the results back from the RIVM.
Evaluation report on the development and results of the protocol
Report of the first pilot measurement
More information at: www.narcis.nl/publication/RecordID/publicat%3A1003825